I suggest the data package was large and they are being thorough.
The guide for timelines to response are 3 to 6 months
- Forums
- ASX - By Stock
- PAR
- FDA delay for ph 3 trial approval
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
5.75%
!
41.0¢

FDA delay for ph 3 trial approval, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
41.0¢ |
Change
-0.025(5.75%) |
Mkt cap ! $160.9M |
Open | High | Low | Value | Volume |
43.5¢ | 43.5¢ | 40.5¢ | $369.6K | 879.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 108499 | 41.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
41.5¢ | 27087 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 75470 | 0.405 |
7 | 48349 | 0.400 |
3 | 17172 | 0.395 |
6 | 39350 | 0.390 |
5 | 184696 | 0.385 |
Price($) | Vol. | No. |
---|---|---|
0.410 | 60 | 1 |
0.415 | 28705 | 3 |
0.420 | 25165 | 4 |
0.425 | 25348 | 3 |
0.430 | 17583 | 2 |
Last trade - 12.06pm 10/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |